BCHE and early-onset autosomal dominant Alzheimer disease: Rivastigmine is a pseudo-irreversible cholinesterase inhibitor used for therapy of Alzheimer’s disease and non-Alzheimer dementia syndromes (including vascular and Parkinson disease dementia) [1].